Is it too early to predict the failure of natalizumab in NMO?
Raghav
R
Govindarajan
Efrain
E
Salgado
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009471:Neuromyelitis Optica / Q000517:prevention & control*
D061067:Antibodies, Monoclonal, Humanized